Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

No reported Gross Profit figures are available to summarize.

Gross Profit history

Currency unavailable · from the income statement

No Gross Profit data reported for this period type.

Gross Profit vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Gross Profit for ODTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PTGXProtagonist Therapeutics, Inc.LTM Jun 2026$281.59M USD+34.6%+19.0%99.9%
ANABAnaptysBio, Inc.LTM Mar 2026$270.54M USD+582.2%—116.4%
SYRESpyre Therapeutics, Inc.LTM Sep 2026$45.25M USD+200.0%—50.0%
ALMSAlumis Inc. Common StockLTM Jun 2026$6.53M USD-66.1%—88.2%
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$6.39M USD+74.8%-31.4%76.3%
AGMBAgomAb Therapeutics N.V. American Depositary SharesFY2024€0 EUR———
IMUXImmunic, Inc.LTM Mar 2026-$33K USD+50.0%——
ORKAOruka Therapeutics, Inc.LTM Sep 2026-$62.25M USD———
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding ODTX) —+62.4%-6.2%88.2%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.